Silco Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	28.6	26.26	28.7	30.76	26.72	53.03
Short-Term Investments	-	-	1.77	18.97	37.91	19.41
Cash & Short-Term Investments	28.6	26.26	30.47	49.73	64.63	72.44
Cash Growth	15.71%	-13.82%	-38.73%	-23.04%	-10.79%	-71.91%
Receivables	435.57	412.83	419.59	377.51	389.24	390.53
Inventory	465.49	450.67	444.1	444.14	457.84	449.45
Prepaid Expenses	-	0.59	0.59	-	0.21	0.21
Other Current Assets	130.23	126.95	160.19	133.55	136.83	139.59
Total Current Assets	1,060	1,017	1,055	1,005	1,049	1,052
Property, Plant & Equipment	1,732	1,743	1,767	1,762	1,671	1,643
Other Long-Term Assets	0	0	-	-0	-0	0
Total Assets	2,792	2,761	2,822	2,767	2,720	2,696
Accounts Payable	9.42	9.52	9.6	9.75	12.33	16.15
Accrued Expenses	5.96	10.48	9.18	9.27	16.93	21.21
Current Portion of Leases	1.29	4.99	4.26	-	4.11	3.77
Current Income Taxes Payable	197.61	188.97	285.19	273.7	255.21	240.41
Other Current Liabilities	6.29	2.17	2.56	3.04	2.33	1.42
Total Current Liabilities	220.58	216.13	310.8	295.76	290.91	282.96
Long-Term Leases	-	-	5.31	-	-	4.11
Long-Term Deferred Tax Liabilities	155.62	154.71	153.71	151.73	150.21	140.5
Other Long-Term Liabilities	-	-0	0	-0	-	0
Total Liabilities	376.19	370.84	469.82	447.5	441.11	427.57
Common Stock	1,038	1,038	1,038	1,038	1,038	1,038
Retained Earnings	1,377	1,352	1,316	1,289	1,251	1,230
Comprehensive Income & Other	-	-	-1.15	-6.92	-10.69	-0.37
Shareholders' Equity	2,415	2,390	2,352	2,320	2,279	2,268
Total Liabilities & Equity	2,792	2,761	2,822	2,767	2,720	2,696
Total Debt	1.29	4.99	9.57	-	4.11	7.89
Net Cash (Debt)	27.31	21.27	20.9	49.73	60.51	64.56
Net Cash Growth	47.06%	1.76%	-57.97%	-17.82%	-6.26%	-74.97%
Net Cash Per Share	0.26	0.20	0.20	0.48	0.58	0.62
Filing Date Shares Outstanding	107.68	103.81	103.81	103.81	103.81	103.81
Total Common Shares Outstanding	107.68	103.81	103.81	103.81	103.81	103.81
Working Capital	839.32	801.16	744.14	709.17	757.83	769.27
Book Value Per Share	22.43	23.02	22.66	22.35	21.95	21.85
Tangible Book Value	2,415	2,390	2,352	2,320	2,279	2,268
Tangible Book Value Per Share	22.43	23.02	22.66	22.35	21.95	21.85
Land	-	74.85	74.85	74.85	74.85	74.85
Buildings	-	1,111	1,083	1,004	880.25	700.05
Machinery	-	1,609	1,576	1,524	1,443	1,320
Construction In Progress	-	137.32	128.1	174.96	197.38	394.59